Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jan;6(1):40-7.
doi: 10.1242/dmm.009795.

Learning from a paradox: recent insights into Fanconi anaemia through studying mouse models

Affiliations
Review

Learning from a paradox: recent insights into Fanconi anaemia through studying mouse models

Sietske T Bakker et al. Dis Model Mech. 2013 Jan.

Abstract

Fanconi anaemia (FA) is a rare autosomal recessive or X-linked inherited disease characterised by an increased incidence of bone marrow failure (BMF), haematological malignancies and solid tumours. Cells from individuals with FA show a pronounced sensitivity to DNA interstrand crosslink (ICL)-inducing agents, which manifests as G2-M arrest, chromosomal aberrations and reduced cellular survival. To date, mutations in at least 15 different genes have been identified that cause FA; the products of all of these genes are thought to function together in the FA pathway, which is essential for ICL repair. Rapidly following the discovery of FA genes, mutant mice were generated to study the disease and the affected pathway. These mutant mice all show the characteristic cellular ICL-inducing agent sensitivity, but only partially recapitulate the developmental abnormalities, anaemia and cancer predisposition seen in individuals with FA. Therefore, the usefulness of modelling FA in mice has been questioned. In this Review, we argue that such scepticism is unjustified. We outline that haematopoietic defects and cancer predisposition are manifestations of FA gene defects in mice, albeit only in certain genetic backgrounds and under certain conditions. Most importantly, recent work has shown that developmental defects in FA mice also arise with concomitant inactivation of acetaldehyde metabolism, giving a strong clue about the nature of the endogenous lesion that must be repaired by the functional FA pathway. This body of work provides an excellent example of a paradox in FA research: that the dissimilarity, rather than the similarity, between mice and humans can provide insight into human disease. We expect that further study of mouse models of FA will help to uncover the mechanistic background of FA, ultimately leading to better treatment options for the disease.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Discordance and similarity between humans with FA and FA mouse models. FA-associated phenotypes in humans and mice are illustrated in a Venn-like diagram. FA phenotypes (lower diagram) are depicted in the common area between the two circles when shared between humans and mice or further away from the common area when phenotypes only partially overlap. We propose that, due to environmental and genetic differences between humans and laboratory mice (upper diagram), humans rely on an effective FA pathway to ensure normal development and tumour suppression, whereas mice are less dependent on an active FA pathway.

References

    1. Agoulnik A. I., Lu B., Zhu Q., Truong C., Ty M. T., Arango N., Chada K. K., Bishop C. E. (2002). A novel gene, Pog, is necessary for primordial germ cell proliferation in the mouse and underlies the germ cell deficient mutation, gcd. Hum. Mol. Genet. 11, 3047–3053 - PubMed
    1. Alpi A. F., Pace P. E., Babu M. M., Patel K. J. (2008). Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol. Cell 32, 767–777 - PubMed
    1. Alter B. P. (2003). Cancer in Fanconi anemia, 1927–2001. Cancer 97, 425–440 - PubMed
    1. Alter B. P., Rosenberg P. S., Brody L. C. (2007). Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J. Med. Genet. 44, 1–9 - PMC - PubMed
    1. Auerbach A. D. (2009). Fanconi anemia and its diagnosis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 668, 4–10 - PMC - PubMed

Publication types

Substances